Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » Qiagen Gets FDA Approval for CMV Assay on QiaSymphony Platform

Qiagen Gets FDA Approval for CMV Assay on QiaSymphony Platform

Jun 06, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Qiagen said today that its Artus CMV QS-RGQ molecular diagnostic kit for use on the QiaSymphony platform has received premarket approval from the US Food and Drug Administration.

The real-time PCR assay is designed to be used with human plasma samples, and is intended to aid in the management of solid organ transplant patients who are undergoing anti-cytomegalovirus therapy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Spinning an FDA "Cocoon"

The New York Times reports on how the US Food and Drug Administration has attempted to gird against pressure from the White House.

Technical, But Key Meeting

Independent advisors to the US Food and Drug Administration are to meet this week to discuss how they will make SARS-CoV-2 vaccine recommendations, the Washington Post reports.

Gene for When to Go

Researchers have identified a gene involved in how people determine when to urinate.

Genome Research Papers on Chromatin Accessibility, Malaria Mosquitoes, Bacterial Pan-Genome Method

In Genome Research this week: assay for profiling chromatin accessibility, analysis of genetic variants among malaria-transmitting mosquitoes, and more.

Oct
28
Featured Webinar

How Low Can You Go? Reduce Breeding Costs with an Optimized Genotyping and Analysis Strategy

Sponsored by
NRGene

Molecular breeding methods such as genomic selection and genome-wide association studies often require high-density genotypic data from many samples, but the cost and complexity of genotyping at this scale may be prohibitive.

Oct
29
Featured Webinar

How to Train Your DRAGEN for Pathology Informatics

Sponsored by
Illumina

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Nov
05
Featured Webinar

Beyond Traditional Biopsy for Esophageal Cancer: Novel Sampling Methods to Improve Patient Care

Sponsored by
Roche

This webinar will provide an overview of novel proximal and distal sampling methods that have promise to improve patient outcomes from esophageal cancer.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In PCR

  1. Thermo Fisher Scientific Q3 Revenues Soar 36 Percent

  2. BD, CerTest Biotec Get CE-IVD Mark for Combination COVID-19, Influenza, RSV Test on BD Max

  3. Thermo Fisher Scientific Continues to See Strong Demand for Pandemic-Related Products and Services

    Premium

  4. Interdisciplinary NIST Team Claims qPCR Improvements Using Unusual Math Tweaks

    Premium

  5. Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.